Tharimmune, Inc.
THAR| Date | Action | ETF | Shares | Close | Est. total |
|---|---|---|---|---|---|
| 26.02.17 | BUY | ARKF | 14,675 | $4.74 | $69.6K |
| 26.02.13 | BUY | ARKF | 3,540 | $4.48 | $15.9K |
| 26.02.12 | BUY | ARKF | 24,430 | $4.28 | $104.6K |
| 26.02.11 | BUY | ARKF | 31,808 | $4.35 | $138.4K |
| 26.02.09 | BUY | ARKF | 54,600 | $4.37 | $238.6K |
| 26.02.06 | BUY | ARKF | 56,187 | $4.14 | $232.6K |
Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
Analyst Consensus
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Tharimmune, Inc. is a company focused on advancing institutional blockchain adoption and the digitization of financial markets through its Canton Coin and network support. It also engages in clinical-stage biotechnology research and development. Previously known as Hillstream BioPharma, the company aims to bridge the gap between blockchain technology and traditional finance.
AI-generated summary. Not investment advice.
Related ARK stocks
Explore companies with similar themes or neighboring ARK trading activity.